Immunopathology of TB: Studying the role of the lymph nodes in the TB spectrum.
Researchers working on a novel study of the lymph nodes of humans discuss this complex project which is studying lymph node immunology, and the role of these organs in the progression to TB disease with a Wellcome Leap grant.
Professor Mark Hatherill addresses United Nations High-level Meeting on Tuberculosis
SEPTEMBER 2023: Prof Mark Hatherill, addressed the UN High-level Meeting on Tuberculosis, calling for a quantum jump in TB vaccine research and development (R&D) funding, to deliver the transformative tools needed to end the TB pandemic.
Titan Vaccine Research Project
Dr Munyaradzi Musvosvi speaks about the Titan Vaccine Research Project which will allow the selection of the most promising TB vaccine candidates.
Phase 1b/2a clinical trial in adults of novel TB vaccine candidate MTBVAC shows promising results.
Findings from the IAVI A-050 study, published in Lancet Global Health, demonstrate that vaccination with MTBVAC caused similar or stronger immune responses compared to the BCG vaccine in adults, of MTBVAC were as safe as BCG.
Seminar: 23 July 2025 Beyond the Cough: Non-Sputum Strategies for TB Diagnosis
On Wednesday 23 July 2025, Dr Simon Mendelsohn will present a paper titled: "Beyond the Cough: Non-Sputum Strategies for TB Diagnosis" at a IDM seminar.
Read more
News from the South African Tuberculosis Vaccine Initiative.
SATVI -led study finds four in five adults with TB have no symptoms
A SATVI-led study published in The Lancet Global Health, found that most adult TB cases in households with an infected member show no symptoms at screening. Researchers urge TB testing for high-risk groups in hard-hit countries.
Read more
Dr Simon Mendelsohn receives UCT College of Fellows "Young Researchers Award"
SATVI's Dr Simon Mendelsohn, has been named one of three recipients of the prestigious 2025 College of Fellows’ Young Researcher Award.
Read more
Vacancy: Postdoctoral Fellowship in TB Immunology
SATVI is inviting applications for a postdoctoral fellowship to conduct immunology research on TB vaccines and immunopathogenesis in humans.
Read more
SATVI awarded Wellcome Trust Discovery grant for Immunopathology study across TB Infection and the TB disease spectrum
Drs. Rozot, Taylor & Prof Scriba have been awarded a grant from the Wellcome Trust Discovery Award to study the protective immunity by studying human tissue samples from individuals with incidental TB infection who died from non-TB causes.
Read more
Vacancies
No vacancies found
Previous highlights
Professor Mark Hatherill addresses United Nations High-level Meeting on Tuberculosis
SEPTEMBER 2023: Prof Mark Hatherill, addressed the UN High-level Meeting on Tuberculosis, calling for a quantum jump in TB vaccine research and development (R&D) funding, to deliver the transformative tools needed to end the TB pandemic.
Read more
Phase 1b/2a clinical trial in adults of novel TB vaccine candidate MTBVAC shows promising results.
Findings from the IAVI A-050 study, published in Lancet Global Health, demonstrate that vaccination with MTBVAC caused similar or stronger immune responses compared to the BCG vaccine in adults, of MTBVAC were as safe as BCG.
Read more
Upcoming Events
2025 Union Conference on Lung Health, 18-22 November 2025
(Ends 22 November 2025)
More infoThe world's largest lung health conference, the World Conference on Lung Health, will take place at the Bella Center in Copenhagen, Denmark from 18-22 November 2025.